Zealand Pharma AS 2025 AR2
The report highlights Zealand Pharma's significant progress in 2025, notably its transformative partnership with Roche for petrelintide, which included a USD 1.4 billion upfront payment. The company launched its Metabolic Frontier 2030 strategy, aiming to establish leadership in obesity and metabolic health with five planned launches by 2030. On the sustainability front, Zealand Pharma committed to the Science Based Targets initiative (SBTi) with approved near-term targets, achieving a 57% reduction in Scope 1 and 2 emissions. Additionally, the company joined the UN Global Compact, expanded its Expanded Access Program for rare disease patients, and maintained high employee engagement during its rapid organizational growth.
Company: Zealand Pharma AS
Sector: Health Care
Country: Denmark
Year: 2025
Type: AR2
Pages: 192
Zealand Pharma AS
Annual Report
The report highlights Zealand Pharma's significant progress in 2025, notably its transformative partnership with Roche for petrelintide, which included a USD 1.4 billion upfront payment. The company launched its Metabolic Frontier 2030 strategy, aiming to establish leadership in obesity and metabolic health with five planned launches by 2030. On the sustainability front, Zealand Pharma committed to the Science Based Targets initiative (SBTi) with approved near-term targets, achieving a 57% reduction in Scope 1 and 2 emissions. Additionally, the company joined the UN Global Compact, expanded its Expanded Access Program for rare disease patients, and maintained high employee engagement during its rapid organizational growth.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees